Used in organic synthesis as a building block for pharmaceuticals, particularly in the development of kinase inhibitors and other bioactive molecules. Its boronic acid group enables Suzuki-Miyaura cross-coupling reactions, allowing for the formation of carbon-carbon bonds in drug intermediates. The fluorine atoms enhance binding selectivity and metabolic stability in final drug compounds. Commonly employed in the synthesis of anti-cancer agents and anti-inflammatory drugs due to its ability to modulate enzyme activity and improve pharmacokinetic properties.